Jean-Christophe Olivier

Professor of Drug Formulation

Research area: Drug delivery systems

Key words: Microsphere, nanosphere, aerosol, lung delivery


tel: (33) 5 49 45 45 92

Address: INSERM U1070
Pôle Biologie Santé
1 rue Georges Bonnet
86022 Poitiers cedex

Main recent publications:

A preclinical pharmacokinetic modeling approach to the biopharmaceutical characterization of immediate and microsphere-based sustained release pulmonary formulations of rifampicin.
Doan TV, Grégoire N, Lamarche I, Gobin P, Marchand S, Couet W, Olivier JC.
Eur J Pharm Sci. 2013 ; 48(1-2):223-230.

Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting.
Diab R, Brillault J, Bardy A, Gontijo AV, Olivier JC.
Int J Pharm. 2012 ;436(1-2):833-9.

Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV, Couet W, Olivier JC.
Int J Pharm. 2011 ; 414(1-2):112-7.

Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
Tewes F, Brillault J, Couet W, Olivier JC.
J Control Release. 2008 ; 129(2):93-9.

Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (-/-) CF-1 mice.
Pereira de Oliveira M, Garcion E, Venisse N, Benoit JP, Couet W, Olivier JC.
Pharm Res. 2005; 22(11):1898-1905.


Menu principal

Haut de page